Akshay K. Vaishnaw
2019
In 2019, Akshay K. Vaishnaw earned a total compensation of $3.1M as President, Research and Development at Alnylam Pharmaceuticals, a 18% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $378,680 |
|---|---|
| Option Awards | $1,654,494 |
| Salary | $586,530 |
| Stock Awards | $460,360 |
| Other | $20,888 |
| Total | $3,100,952 |
Vaishnaw received $1.7M in option awards, accounting for 53% of the total pay in 2019.
Vaishnaw also received $378.7K in non-equity incentive plan, $586.5K in salary, $460.4K in stock awards and $20.9K in other compensation.
Rankings
In 2019, Akshay K. Vaishnaw's compensation ranked 3,959th out of 13,971 executives tracked by ExecPay. In other words, Vaishnaw earned more than 71.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,959 out of 13,971 | 72nd |
Division Manufacturing | 1,428 out of 5,695 | 75th |
Major group Chemicals And Allied Products | 502 out of 2,194 | 77th |
Industry group Drugs | 424 out of 1,880 | 77th |
Industry Pharmaceutical Preparations | 322 out of 1,392 | 77th |
Source: SEC filing on April 2, 2021.
Vaishnaw's colleagues
We found five more compensation records of executives who worked with Akshay K. Vaishnaw at Alnylam Pharmaceuticals in 2019.
2019
John Maraganore
Alnylam Pharmaceuticals
Chief Executive Officer
2019
Jeffrey Poulton
Alnylam Pharmaceuticals
Chief Financial Officer
2019
Yvonne Greenstreet
Alnylam Pharmaceuticals
Chief Operating Officer
2019
Barry Greene
Alnylam Pharmaceuticals
Former President
2019
Laurie Keating
Alnylam Pharmaceuticals